9/ 2. 167 patienter (0, 42%) for lumiracoxib mod 8/ 2. 159 patienter (0, 37%) for NSAID, med et RF på 1, 14 [95% KI 0, 44- 2, 95] p=0, 7899.
lumiracoxib versus 8/ 2159 patients (0.37%) for NSAIDs, with a HR of 1.14 [95% CI 0.44-2.95] p=0.7899.